The overall post-covid market is much bigger than that for patients showing immediate - normal or severe - symptoms. The group of people who initially didn't have symptoms at all is probably bigger, but only widespread tests could provide insight here and I doubt that there will be enough wisdom & understanding in order to bring forward these kind of measures.